Luteolin inhibits proliferation and affects the function of stimulated rat synovial fibroblasts

Cell Biology International

Volumn 33, Issue 2, 2009, Pages 135-147

  Hou, Yanan ^a,b   Wu, Jiacai ^a,b   Huang, Qin ^a,c   Guo, Lihe ^a,c  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c Cellstar Biotechnologies Company   (China)

Author keywords

Collagen induced arthritis (CIA); Luteolin; Proliferation; Rheumatoid arthritis (RA); Synovial fibroblast (SFB)

Indexed keywords

COLLAGEN; INTERLEUKIN 15; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME RELEASE; FIBROBLAST; MALE; NONHUMAN; RAT; RHEUMATOID ARTHRITIS; SYNOVIUM; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL DIVISION; CELL PROLIFERATION; CYTOKINES; DRUG SYNERGISM; FIBROBLASTS; G2 PHASE; LUTEOLIN; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASES; RATS; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 58749115376     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2008.10.005     Document Type: Article

References (46)

1. Bagli E., Stefaniotou M., Morbidelli L., Ziche M., Psillas K., Murphy C., et al. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3′-kinase activity. Cancer Res 64 (2004) 7936-7946
2. Bodolay E., Koch A.E., Kim J., Szegedi G., and Szekanecz Z. Angiogenesis and chemokines in rheumatoid arthritis and other systemic inflammatory rheumatic diseases. J Cell Mol Med 6 (2002) 357-376
3. Campo G.M., Avenoso A., Campo S., Ferlazzo A.M., Altavilla D., and Calatroni A. Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats. Arthritis Res Ther 5 (2003) R122-R131
4. Casagrande F., and Darbon J.M. Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochem Pharmacol 61 (2001) 1205-1215
5. Di Carlo G., Mascolo N., Izzo A.A., and Capasso F. Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci 65 (1999) 337-353
6. DiBattista J.A., Pelletier J.P., Zafarullah M., Fujimoto N., Obata K., and Martel-Pelletier J. Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts. J Rheumatol Suppl 43 (1995) 123-128
7. Edwards J.C.W. The synovium. In: Klippel J.H., and Dieppe P.A. (Eds). Rheumatology (1997), Mosby, Lodon 5/6.1-5/6.8
8. Faruqi T.R., and DiCorleto P.E. IFN-gamma inhibits double-stranded RNA-induced E-selectin expression in human endothelial cells. J Immunol 159 (1997) 3989-3994
9. Feldmann M., and Maini R.N. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?. Annu Rev Immunol 19 (2001) 163-196
10. Gay S., Gay R.E., and Koopman W.J. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?. Ann Rheum Dis 52 Suppl. 1 (1993) S39-S47
11. Grimbacher B., Aicher W.K., Peter H.H., and Eibel H. TNF-alpha induces the transcription factor Egr-1, pro-inflammatory cytokines and cell proliferation in human skin fibroblasts and synovial lining cells. Rheumatol Int 17 (1998) 185-192
12. Gutierrez-Venegas G., Kawasaki-Cardenas P., Arroyo-Cruz S.R., and Maldonado-Frias S. Luteolin inhibits lipopolysaccharide actions on human gingival fibroblasts. Eur J Pharmacol 541 (2006) 95-105
13. Holmdahl R., Andersson M.E., Goldschmidt T.J., Jansson L., Karlsson M., Malmstrom V., et al. Collagen induced arthritis as an experimental model for rheumatoid arthritis. Immunogenetics, pathogenesis and autoimmunity. Apmis 97 (1989) 575-584
14. Hwang S.Y., Kim J.Y., Kim K.W., Park M.K., Moon Y., Kim W.U., et al. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways. Arthritis Res Ther 6 (2004) R120-R128
15. Iwanaga T., Shikichi M., Kitamura H., Yanase H., and Nozawa-Inoue K. Morphology and functional roles of synoviocytes in the joint. Arch Histol Cytol 63 (2000) 17-31
16. Jiang W., Jimenez G., Wells N.J., Hope T.J., Wahl G.M., Hunter T., et al. PRC1: a human mitotic spindle-associated CDK substrate protein required for cytokinesis. Mol Cell 2 (1998) 877-885
17. Jones D.H., Kong Y.Y., and Penninger J.M. Role of RANKL and RANK in bone loss and arthritis. Ann Rheum Dis 61 Suppl. 2 (2002) ii32-ii69
18. Jungel A., Distler J.H., Kurowska-Stolarska M., Seemayer C.A., Seibl R., Forster A., et al. Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis. Arthritis Rheum 50 (2004) 1468-1476
19. Kim H.K., Cheon B.S., Kim Y.H., Kim S.Y., and Kim H.P. Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem Pharmacol 58 (1999) 759-765
20. Kim S.H., Shin K.J., Kim D., Kim Y.H., Han M.S., Lee T.G., et al. Luteolin inhibits the nuclear factor-kappa B transcriptional activity in rat-1 fibroblasts. Biochem Pharmacol 66 (2003) 955-963
21. Kitasato H., Noda M., Akahoshi T., Okamoto R., Koshino T., Murakami Y., et al. Activated Ras modifies the proliferative response of rheumatoid synovial cells to TNF-alpha and TGF-alpha. Inflamm Res 50 (2001) 592-597
22. Kobayashi T., Nakata T., and Kuzumaki T. Effect of flavonoids on cell cycle progression in prostate cancer cells. Cancer Lett 176 (2002) 17-23
23. Kontny E., Rudnicka W., Chorazy-Massalska M., Marcinkiewicz J., and Maslinski W. Taurine chloramine inhibits proliferation of rheumatoid arthritis synoviocytes by triggering a p53-dependent pathway. Inflamm Res 55 (2006) 446-455
24. Kunisch E., Gandesiri M., Fuhrmann R., Roth A., Winter R., and Kinne R.W. Predominant activation of MAP kinases and pro-destructive/pro-inflammatory features by TNF alpha in early-passage synovial fibroblasts via TNF receptor-1: failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritis. Ann Rheum Dis 66 (2007) 1043-1051
25. Lee L.T., Huang Y.T., Hwang J.J., Lee P.P., Ke F.C., Nair M.P., et al. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res 22 (2002) 1615-1627
26. Lee W.J., Wu L.F., Chen W.K., Wang C.J., and Tseng T.H. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways. Chem Biol Interact 160 (2006) 123-133
27. Manju V., Balasubramaniyan V., and Nalini N. Rat colonic lipid peroxidation and antioxidant status: the effects of dietary luteolin on 1,2-dimethylhydrazine challenge. Cell Mol Biol Lett 10 (2005) 535-551
28. Manju V., and Nalini N. Protective role of luteolin in 1,2-dimethylhydrazine induced experimental colon carcinogenesis. Cell Biochem Funct 25 (2007) 189-194
29. Martel-Pelletier J., Welsch D.J., and Pelletier J.P. Metalloproteases and inhibitors in arthritic diseases. Best Pract Res Clin Rheumatol 15 (2001) 805-829
30. McInnes I.B., and Gracie J.A. Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. Curr Opin Pharmacol 4 (2004) 392-397
31. Monasterio A., Urdaci M.C., Pinchuk I.V., Lopez-Moratalla N., and Martinez-Irujo J.J. Flavonoids induce apoptosis in human leukemia U937 cells through caspase- and caspase-calpain-dependent pathways. Nutr Cancer 50 (2004) 90-100
32. Muller-Ladner U., Gay R.E., and Gay S. Activation of synoviocytes. Curr Opin Rheumatol 12 (2000) 186-194
33. Muller-Ladner U., Kriegsmann J., Franklin B.N., Matsumoto S., Geiler T., Gay R.E., et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 149 (1996) 1607-1615
34. Qu Z., Garcia C.H., O'Rourke L.M., Planck S.R., Kohli M., and Rosenbaum J.T. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. Arthritis Rheum 37 (1994) 212-220
35. Shimoi K., Okada H., Furugori M., Goda T., Takase S., Suzuki M., et al. Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans. FEBS Lett 438 (1998) 220-224
36. Smeets T.J., Kraan M.C., van Loon M.E., and Tak P.P. Tumor necrosis factor alpha blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue. Arthritis Rheum 48 (2003) 2155-2162
37. Tarner I.H., Muller-Ladner U., Gay R.E., Fathman C.G., and Gay S. The pathogenesis of rheumatoid arthritis gene transfer to detect novel targets for treatment frontiers in autoimmunity (2003), IOS Press, Amsterdam p. 315-46
38. Tolboom T.C., Pieterman E., van der Laan W.H., Toes R.E., Huidekoper A.L., Nelissen R.G., et al. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann Rheum Dis 61 (2002) 975-980
39. Tracey K.J., Fong Y., Hesse D.G., Manogue K.R., Lee A.T., Kuo G.C., et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330 (1987) 662-664
40. Trentham D.E. Collagen arthritis as a relevant model for rheumatoid arthritis. Arthritis Rheum 25 (1982) 911-916
41. Wajant H., Pfizenmaier K., and Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 10 (2003) 45-65
42. Wooley P.H., Luthra H.S., Stuart J.M., and David C.S. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 154 (1981) 688-700
43. Xagorari A., Papapetropoulos A., Mauromatis A., Economou M., Fotsis T., and Roussos C. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J Pharmacol Exp Ther 296 (2001) 181-187
44. Yee S.B., Lee J.H., Chung H.Y., Im K.S., Bae S.J., Choi J.S., et al. Inhibitory effects of luteolin isolated from Ixeris sonchifolia Hance on the proliferation of HepG2 human hepatocellular carcinoma cells. Arch Pharm Res 26 (2003) 151-156
45. Yielding K.L., Tomkins G.M., and Bunim J.J. Synthesis of hyaluronic acid by human synovial tissue slices. Science 125 (1957) 1300
46. Zhang H.G., Wang Y., Xie J.F., Liang X., Liu D., Yang P., et al. Regulation of tumor necrosis factor alpha-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt. Arthritis Rheum 44 (2001) 1555-1567